The Effect of Tibolone on Climacteric Symptoms of Healthy Postmenopausal Women

ABSTRACT: Introduction & Objective: Menopause is related to many symptoms that have an effect on women’s life quality. HRT and its alternatives such as Tibolone are some of the routes for enhancement of different aspects of QoL in menopause. The aim of this study was the comparison of the ef...

Full description

Bibliographic Details
Main Authors: S Moghassemi, S Ziaei
Format: Article
Language:fas
Published: Yasuj University Of Medical Sciences 2009-07-01
Series:Armaghane Danesh Bimonthly Journal
Subjects:
Online Access:http://armaghanj.yums.ac.ir/browse.php?a_code=A-10-1-431&slc_lang=en&sid=1
_version_ 1818026518887006208
author S Moghassemi
S Ziaei
author_facet S Moghassemi
S Ziaei
author_sort S Moghassemi
collection DOAJ
description ABSTRACT: Introduction & Objective: Menopause is related to many symptoms that have an effect on women’s life quality. HRT and its alternatives such as Tibolone are some of the routes for enhancement of different aspects of QoL in menopause. The aim of this study was the comparison of the effects of Tibolone and placebo on climacteric symptoms of healthy menopausal women. Materials & Methods: This is a randomized, prospective clinical study. A total of 96 women with no absolute contraindication for hormone replacement therapy (HRT) that reffered to selected clinics (gynecologic clinics in Fajr and Avesina Hospitals, Aboraihan and Shahid Haidari Polyclinic and an individual clinic) during 2007-2008 were divided into two groups: 41 women in the Tibolone group received Tibolone 2.5 mg/day + Ca-D (500 mg +200 IU) and 45 women in the placebo group received only Ca-D (500 mg +200 IU) for six months. At baseline and after six months, climacteric symptoms were assessed by Greene Climacteric Scale (GCS). Data was analyzed by SPSS version 15. Paired and independent t-test, Chi-Square test and Mann-Whitney were used for analyzing the collected data. Results: Thirty two women in the Tibolone group and 43 women in the placebo completed the study. Comparing the baseline and placebo values, the Tibolone group significantly improved on all of GCS subscales which include: depression, anxiety, somatic, vasomotor symptoms and libido (P<0.05). Conclusion: In postmenopausal women, Tibolone significantly improved all aspects of climacteric symptoms and increased their quality of life. Keywords: Tibolone, menopausal women, Greene Climacteric Scale
first_indexed 2024-12-10T04:33:17Z
format Article
id doaj.art-b665f9dd5b594fe7b38a6c7574117bd5
institution Directory Open Access Journal
issn 1728-6506
1728-6514
language fas
last_indexed 2024-12-10T04:33:17Z
publishDate 2009-07-01
publisher Yasuj University Of Medical Sciences
record_format Article
series Armaghane Danesh Bimonthly Journal
spelling doaj.art-b665f9dd5b594fe7b38a6c7574117bd52022-12-22T02:02:04ZfasYasuj University Of Medical SciencesArmaghane Danesh Bimonthly Journal1728-65061728-65142009-07-011424352The Effect of Tibolone on Climacteric Symptoms of Healthy Postmenopausal WomenS Moghassemi0S Ziaei1 ABSTRACT: Introduction & Objective: Menopause is related to many symptoms that have an effect on women’s life quality. HRT and its alternatives such as Tibolone are some of the routes for enhancement of different aspects of QoL in menopause. The aim of this study was the comparison of the effects of Tibolone and placebo on climacteric symptoms of healthy menopausal women. Materials & Methods: This is a randomized, prospective clinical study. A total of 96 women with no absolute contraindication for hormone replacement therapy (HRT) that reffered to selected clinics (gynecologic clinics in Fajr and Avesina Hospitals, Aboraihan and Shahid Haidari Polyclinic and an individual clinic) during 2007-2008 were divided into two groups: 41 women in the Tibolone group received Tibolone 2.5 mg/day + Ca-D (500 mg +200 IU) and 45 women in the placebo group received only Ca-D (500 mg +200 IU) for six months. At baseline and after six months, climacteric symptoms were assessed by Greene Climacteric Scale (GCS). Data was analyzed by SPSS version 15. Paired and independent t-test, Chi-Square test and Mann-Whitney were used for analyzing the collected data. Results: Thirty two women in the Tibolone group and 43 women in the placebo completed the study. Comparing the baseline and placebo values, the Tibolone group significantly improved on all of GCS subscales which include: depression, anxiety, somatic, vasomotor symptoms and libido (P<0.05). Conclusion: In postmenopausal women, Tibolone significantly improved all aspects of climacteric symptoms and increased their quality of life. Keywords: Tibolone, menopausal women, Greene Climacteric Scalehttp://armaghanj.yums.ac.ir/browse.php?a_code=A-10-1-431&slc_lang=en&sid=1Keywords: Tibolone menopausal women Greene Climacteric Scale
spellingShingle S Moghassemi
S Ziaei
The Effect of Tibolone on Climacteric Symptoms of Healthy Postmenopausal Women
Armaghane Danesh Bimonthly Journal
Keywords: Tibolone
menopausal women
Greene Climacteric Scale
title The Effect of Tibolone on Climacteric Symptoms of Healthy Postmenopausal Women
title_full The Effect of Tibolone on Climacteric Symptoms of Healthy Postmenopausal Women
title_fullStr The Effect of Tibolone on Climacteric Symptoms of Healthy Postmenopausal Women
title_full_unstemmed The Effect of Tibolone on Climacteric Symptoms of Healthy Postmenopausal Women
title_short The Effect of Tibolone on Climacteric Symptoms of Healthy Postmenopausal Women
title_sort effect of tibolone on climacteric symptoms of healthy postmenopausal women
topic Keywords: Tibolone
menopausal women
Greene Climacteric Scale
url http://armaghanj.yums.ac.ir/browse.php?a_code=A-10-1-431&slc_lang=en&sid=1
work_keys_str_mv AT smoghassemi theeffectoftiboloneonclimactericsymptomsofhealthypostmenopausalwomen
AT sziaei theeffectoftiboloneonclimactericsymptomsofhealthypostmenopausalwomen
AT smoghassemi effectoftiboloneonclimactericsymptomsofhealthypostmenopausalwomen
AT sziaei effectoftiboloneonclimactericsymptomsofhealthypostmenopausalwomen